Clinical trial
This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With…
NCT00047840 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00047840 |
|---|---|
| Title | This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. |
| Official title | A Randomized, Double-blind, Multicenter, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 in Combination With Docetaxel (TAXOTERE™) in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-based Chemotherapy. |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line |
| Intervention type | Drug |
| Interventions | ZD6474, Placebo, Docetaxel |
| Enrollment | 129 |
| Start date | Oct 1, 2002 |
| Completion | Sep 1, 2006 |
| First posted | Oct 24, 2002 |
| Last update posted | Aug 25, 2016 |
| Countries | Czechia, Hungary, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: